EVOLENT HEALTH INC - A (EVH) Stock Fundamental Analysis
USA - NYSE:EVH - US30050B1017 - Common Stock
7.41 USD
-0.23 (-3.01%)
7.5 USD
+0.09 (+1.21%)
EVH gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. EVH has a bad profitability rating. Also its financial health evaluation is rather negative. EVH is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year EVH has reported negative net income.
EVH had a negative operating cash flow in the past year.
EVH had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: EVH reported negative operating cash flow in multiple years.
1.2 Ratios
EVH's Return On Assets of -7.52% is fine compared to the rest of the industry. EVH outperforms 62.86% of its industry peers.
Looking at the Return On Equity, with a value of -16.46%, EVH is in line with its industry, outperforming 60.00% of the companies in the same industry.
EVH's Return On Invested Capital of 0.13% is fine compared to the rest of the industry. EVH outperforms 65.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.52% | ||
| ROE | -16.46% | ||
| ROIC | 0.13% |
ROA(3y)-3.35%
ROA(5y)-7.41%
ROE(3y)-7.16%
ROE(5y)-16.17%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Operating Margin, with a value of 0.15%, EVH is in the better half of the industry, outperforming 65.71% of the companies in the same industry.
With a Gross Margin value of 16.36%, EVH is not doing good in the industry: 82.86% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of EVH has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.15% | ||
| PM (TTM) | N/A | ||
| GM | 16.36% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.51%
GM growth 5Y-10.71%
2. Health
2.1 Basic Checks
EVH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for EVH has been increased compared to 1 year ago.
EVH has more shares outstanding than it did 5 years ago.
EVH has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.81, we must say that EVH is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.81, EVH is in line with its industry, outperforming 54.29% of the companies in the same industry.
EVH has a Debt/Equity ratio of 0.73. This is a neutral value indicating EVH is somewhat dependend on debt financing.
EVH's Debt to Equity ratio of 0.73 is on the low side compared to the rest of the industry. EVH is outperformed by 74.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.81 |
ROIC/WACC0.01
WACC8.7%
2.3 Liquidity
EVH has a Current Ratio of 1.01. This is a normal value and indicates that EVH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.01, EVH is doing worse than 74.29% of the companies in the same industry.
EVH has a Quick Ratio of 1.01. This is a normal value and indicates that EVH is financially healthy and should not expect problems in meeting its short term obligations.
EVH's Quick ratio of 1.01 is on the low side compared to the rest of the industry. EVH is outperformed by 74.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.01 | ||
| Quick Ratio | 1.01 |
3. Growth
3.1 Past
EVH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -101.71%.
Measured over the past years, EVH shows a very strong growth in Earnings Per Share. The EPS has been growing by 220.75% on average per year.
EVH shows a decrease in Revenue. In the last year, the revenue decreased by -6.71%.
The Revenue has been growing by 30.04% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-101.71%
EPS 3Y220.75%
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)-6.71%
Revenue growth 3Y41.17%
Revenue growth 5Y30.04%
Sales Q2Q%-31.34%
3.2 Future
The Earnings Per Share is expected to grow by 18.08% on average over the next years. This is quite good.
Based on estimates for the next years, EVH will show a small growth in Revenue. The Revenue will grow by 7.35% on average per year.
EPS Next Y-63.44%
EPS Next 2Y-3.37%
EPS Next 3Y6.39%
EPS Next 5Y18.08%
Revenue Next Year-26.42%
Revenue Next 2Y-2.96%
Revenue Next 3Y2.81%
Revenue Next 5Y7.35%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for EVH. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 12.02 indicates a correct valuation of EVH.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EVH indicates a rather cheap valuation: EVH is cheaper than 88.57% of the companies listed in the same industry.
EVH is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.88, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 12.02 |
4.2 Price Multiples
80.00% of the companies in the same industry are more expensive than EVH, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 12.74 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.37%
EPS Next 3Y6.39%
5. Dividend
5.1 Amount
No dividends for EVH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
7.41
-0.23 (-3.01%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners108.7%
Inst Owner Change0.07%
Ins Owners1.53%
Ins Owner Change2.35%
Market Cap870.75M
Revenue(TTM)2.20B
Net Income(TTM)-185186000
Analysts83.33
Price Target15.98 (115.65%)
Short Float %15.24%
Short Ratio5.89
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-132.11%
Min EPS beat(2)-226.45%
Max EPS beat(2)-37.77%
EPS beat(4)0
Avg EPS beat(4)-171.4%
Min EPS beat(4)-332.96%
Max EPS beat(4)-37.77%
EPS beat(8)4
Avg EPS beat(8)-30.3%
EPS beat(12)7
Avg EPS beat(12)11.34%
EPS beat(16)11
Avg EPS beat(16)446.31%
Revenue beat(2)1
Avg Revenue beat(2)-0.11%
Min Revenue beat(2)-4.24%
Max Revenue beat(2)4.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.95%
Min Revenue beat(4)-4.24%
Max Revenue beat(4)4.03%
Revenue beat(8)4
Avg Revenue beat(8)0.39%
Revenue beat(12)6
Avg Revenue beat(12)0.07%
Revenue beat(16)9
Avg Revenue beat(16)0.78%
PT rev (1m)0%
PT rev (3m)-11.53%
EPS NQ rev (1m)2.85%
EPS NQ rev (3m)14.19%
EPS NY rev (1m)-2.09%
EPS NY rev (3m)-32.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-11.9%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-8.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 12.02 | ||
| P/S | 0.4 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.77 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.74 |
EPS(TTM)-0.02
EYN/A
EPS(NY)0.62
Fwd EY8.32%
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS18.69
BVpS9.57
TBVpS-5.65
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.52% | ||
| ROE | -16.46% | ||
| ROCE | 0.18% | ||
| ROIC | 0.13% | ||
| ROICexc | 0.14% | ||
| ROICexgc | 1.94% | ||
| OM | 0.15% | ||
| PM (TTM) | N/A | ||
| GM | 16.36% | ||
| FCFM | N/A |
ROA(3y)-3.35%
ROA(5y)-7.41%
ROE(3y)-7.16%
ROE(5y)-16.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.51%
GM growth 5Y-10.71%
F-Score2
Asset Turnover0.89
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 7.49 | ||
| Cap/Depr | 28.07% | ||
| Cap/Sales | 1.36% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.01 | ||
| Quick Ratio | 1.01 | ||
| Altman-Z | 0.81 |
F-Score2
WACC8.7%
ROIC/WACC0.01
Cap/Depr(3y)38.35%
Cap/Depr(5y)41.66%
Cap/Sales(3y)1.98%
Cap/Sales(5y)2.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-101.71%
EPS 3Y220.75%
EPS 5YN/A
EPS Q2Q%-133.33%
EPS Next Y-63.44%
EPS Next 2Y-3.37%
EPS Next 3Y6.39%
EPS Next 5Y18.08%
Revenue 1Y (TTM)-6.71%
Revenue growth 3Y41.17%
Revenue growth 5Y30.04%
Sales Q2Q%-31.34%
Revenue Next Year-26.42%
Revenue Next 2Y-2.96%
Revenue Next 3Y2.81%
Revenue Next 5Y7.35%
EBIT growth 1Y239.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year303.86%
EBIT Next 3Y83.64%
EBIT Next 5Y55.33%
FCF growth 1Y-203.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-233.8%
OCF growth 3Y-21.47%
OCF growth 5YN/A
EVOLENT HEALTH INC - A / EVH FAQ
What is the fundamental rating for EVH stock?
ChartMill assigns a fundamental rating of 2 / 10 to EVH.
What is the valuation status for EVH stock?
ChartMill assigns a valuation rating of 2 / 10 to EVOLENT HEALTH INC - A (EVH). This can be considered as Overvalued.
Can you provide the profitability details for EVOLENT HEALTH INC - A?
EVOLENT HEALTH INC - A (EVH) has a profitability rating of 2 / 10.
What is the financial health of EVOLENT HEALTH INC - A (EVH) stock?
The financial health rating of EVOLENT HEALTH INC - A (EVH) is 1 / 10.